Matthew R. Plooster, Director at KEMPHARM, INC (KMPH), bought 5,000 shares at $4.97 ($25K) on 2022-05-18, disclosed to the SEC on 2022-05-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.94 | 695 | $3K | 13.9% |
| 2 | $4.95 | 915 | $5K | 18.3% |
| 3 | $4.96 | 3,051 | $15K | 61.1% |
| 4 | $4.97 | 339 | $2K | 6.8% |
| Total | $4.96 avg | 5,000 | $25K | 100% |